Publications for Elisabeth Skogh
Co-author map based on ISI articles 2007-

Publications mentioned in social media 5 times*

Keywords

taurine smoking smokers serum schizophrenia plasma patients olanzapine ola ng/ml kyna gsh fluid drug dmo csf controls cerebrospinal c/d acid

Journal Articles

Martin Samuelsson, Elisabeth Skogh, Kristina Lundberg, Magnus Vrethem and Karin Öllinger
  Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia
  Psychiatry Research, 2013, 210(3), 819-824.

Mao Mao, Elisabeth Skogh, Maria Gabriella Scordo and Marja-Liisa Dahl
  Letter: Interindividual Variation in Olanzapine Concentration Influenced by UGT1A4 L48V Polymorphism in Serum and Upstream FMO Polymorphisms in Cerebrospinal Fluid
 
Altmetric usage: 3

  Journal of Clinical Psychopharmacology, 2012, 32(2), 287-289.
 Web of Science® Times Cited: 3

Klas R Linderholm, Elisabeth Skogh, Sara K Olsson, Marja-Liisa Dahl, Maria Holtze, Göran Engberg, Martin Samuelsson and Sophie Erhardt
  Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
 
Altmetric usage: 1

  Schizophrenia Bulletin, 2012, 38(3), 426-432.
 Web of Science® Times Cited: 26

Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson and Marja-Liisa Dahl
  High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug
 
Altmetric usage: 1

  Journal of Clinical Psychopharmacology, 2011, 31(1), 4-9.
 Web of Science® Times Cited: 16

Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson and M.L. Dahl
  Olanzapine in serum and cerebrospinal fluid in patients with schizophrenia or schizoaffective disorder
  European Neuropsychopharmacology, 2010, 20(Suppl. 3), S469-S469.

Martin Josefsson, Markus Roman, Elisabeth Skogh and Marja-Liisa Dahl
  Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid
  Journal of Pharmaceutical and Biomedical Analysis, 2010, 53(3), 576-582.
 Web of Science® Times Cited: 14

Linda K Nilsson-Todd, Conny Nordin, Erik G Jönsson, Elisabeth Skogh and Sophie Erhardt
  Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - Correlation with monoamine metabolites
  Acta Neuropsychiatrica, 2007, 19(1), 45-52.
 Web of Science® Times Cited: 3

Elisabeth Skogh, Margareta Reis, Marja-Liisa Dahl, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 518-526.
 Web of Science® Times Cited: 59

Sophie Erhardt, Kaj Blennow, Conny Nordin, Elisabeth Skogh, Leif Lindström and Göran Engberg
  Kynurenic acid levels ae elevated in the cerebrospinal fluid of patients with schizophrenia
  Neuroscience Letters, 2001, 313(1-2), 96-98.
 Web of Science® Times Cited: 154

Elisabeth Skogh, Finn Bengtsson and Conny Nordin
  Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.
  Therapeutic Drug Monitoring, 1999, 21, 580-582.

Licentiate Theses

Elisabeth Skogh
  Studies on Variability in Olanzapine Disposition
  2011.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.